Carol Giltner Gallagher

Insider Reports History

Location
Del Mar, CA
Signature
/s/ John Chao, Attorney-in-Fact for Carol Gallagher
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carol Giltner Gallagher:

Company Role Class Num Shares Value Price $ Report Date Ownership
Atara Biotherapeutics, Inc. Director Common Stock 33,012 $249,570 $7.56 10 Jun 2025 Direct
Certara, Inc. Director Common Stock 7,059 $127,062 $18.00 15 Jun 2021 Direct
PMV Pharmaceuticals, Inc. Director Stock Option (right to buy) 33,500 05 Jun 2025 Indirect
Frazier Lifesciences Acquisition Corp Director Class B Ordinary Shares 0 22 Nov 2022 Direct
Mirati Therapeutics, Inc. Director Common Stock 0 $59.02 23 Jan 2024 Direct
Mirati Therapeutics, Inc. Director Option to Purchase Common Stock 0 23 Jan 2024 Direct
PMV Pharmaceuticals, Inc. Director Stock Option (right to buy) 0 05 Jun 2025 Direct
Turning Point Therapeutics, Inc. Director Stock Option (right to buy) 0 17 Aug 2022 By the Gallagher Revocable Trust dated May 10, 2011
Turning Point Therapeutics, Inc. Director Stock Option (right to buy) 0 17 Aug 2022 Direct

Insider Reports Filed by Carol Giltner Gallagher

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATRA Atara Biotherapeutics, Inc. 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 20:39
PMVP PMV Pharmaceuticals, Inc. 05 Jun 2025 3 $0 4 Director 09 Jun 2025, 16:23
PMVP PMV Pharmaceuticals, Inc. 06 Jun 2024 3 $0 4 Director 10 Jun 2024, 16:21
ATRA Atara Biotherapeutics, Inc. 31 Mar 2024 1 $0 4 Director 02 Apr 2024, 18:12
/report/000114036124003527-gallagher-carol-giltner-2024-01-23 Mirati Therapeutics, Inc. 23 Jan 2024 3 $0 4 Director 23 Jan 2024, 20:37
/report/000162828024000312-gallagher-carol-giltner-2023-12-29 Mirati Therapeutics, Inc. 29 Dec 2023 1 +$399,970 4 Director 03 Jan 2024, 18:27
ATRA Atara Biotherapeutics, Inc. 13 Nov 2023 2 +$68,214 4 Director 15 Nov 2023, 17:07
/report/000162828023023351-gallagher-carol-giltner-2023-06-22 Mirati Therapeutics, Inc. 22 Jun 2023 2 $0 4 Director 23 Jun 2023, 17:18
/report/000162828023023349-gallagher-carol-giltner-2023-06-22 Mirati Therapeutics, Inc. 22 Jun 2023 0 $0 3 Director 23 Jun 2023, 17:16
PMVP PMV Pharmaceuticals, Inc. 08 Jun 2023 3 $0 4 Director 12 Jun 2023, 17:19
ATRA Atara Biotherapeutics, Inc. 31 May 2023 2 $0 4 Director 02 Jun 2023, 19:09
/report/000089924322036923-gallagher-carol-giltner-2022-11-22 Frazier Lifesciences Acquisition Corp 22 Nov 2022 1 $0 4 Director 23 Nov 2022, 15:23
PMVP PMV Pharmaceuticals, Inc. 04 Nov 2022 3 $0 4 Director 08 Nov 2022, 15:22
PMVP PMV Pharmaceuticals, Inc. 03 Nov 2022 0 $0 3 Director 08 Nov 2022, 15:18
/report/000120919122046284-gallagher-carol-giltner-2022-08-17 Turning Point Therapeutics, Inc. 17 Aug 2022 3 $0 4 Director 17 Aug 2022, 16:38
ATRA Atara Biotherapeutics, Inc. 23 Jun 2022 2 $0 4 Director 27 Jun 2022, 16:48
CERT Certara, Inc. 15 Jun 2021 1 $0 4 Director 16 Jun 2021, 08:48
CERT Certara, Inc. 15 Jun 2021 0 $0 3 Director 16 Jun 2021, 08:47
ATRA Atara Biotherapeutics, Inc. 08 Jun 2021 2 $0 4 Director 09 Jun 2021, 19:09
/report/000120919121038333-gallagher-carol-giltner-2021-06-02 Turning Point Therapeutics, Inc. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 17:39